Kinnakeet Biotechnology

Kinnakeet Biotechnology LLC is a private, revenue-generating services company providing specialized protein expression and purification services using the baculovirus insect cell system. Leveraging the deep expertise of its founders, the company operates as a nimble CRO, offering clients direct access to experienced scientists for project design and execution. Its business model is built on delivering reliable, high-quality protein production at competitive prices, which has resulted in a strong reputation and a >90% repeat customer rate. While not developing its own therapeutic pipeline, Kinnakeet plays a critical supporting role in the broader biotech ecosystem, particularly in oncology and antibody drug discovery.

Baculovirus expression vector system (BEVS) in insect cells for recombinant protein expression and purification.

Kinnakeet competes in the protein expression CRO space against university core facilities, other specialized boutiques, and large global CROs. Its differentiation lies in deep baculovirus expertise, direct scientist access, competitive pricing, and a focus on client relationships, as evidenced by its >90% repeat business rate.